)
AEON Biopharma (AEON) investor relations material
AEON Biopharma Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Management team and governance
President and CEO is Robert Bancroft, who also serves as Principal Executive Officer and Director.
Chief Accounting Officer is Jennifer Sy, serving as Principal Accounting Officer.
Chief Financial Officer is John Bencich, serving as Principal Financial Officer.
Board includes Jost Fischer (Chairman), Robert Palmisano, Shelley Thunen, Eric Carter, Seongsoo Park, and Marc Forth.
Offering details and pricing
Registration statement filed for Class A common stock, $0.0001 par value per share.
Five-Year Milestone Warrants registered at 115% of the assumed public offering price.
Incremental registration fee paid for the increased aggregate offering price.
Securities may be offered on a delayed or continuous basis under Rule 415.
Underwriters and syndicate
Underwriting Agreement dated January 6, 2025, with Aegis Capital Corp.
Sales Agreement dated August 14, 2024, with Leerink Partners LLC.
- Raises $11M via equity and warrants to fund biosimilar development, but faces major financial risk.AEON
Registration filing8 Jul 2026 - ABP-450 aims to disrupt BOTOX®'s dominance with full-label biosimilarity and broad market access.AEON
Corporate presentation14 May 2026 - Q1 2026 net loss was $11.8M; positive FDA feedback and debt reduction support future plans.AEON
Q1 202614 May 2026 - Vote on director elections and auditor ratification at the June 2026 annual meeting.AEON
Proxy filing29 Apr 2026 - Shareholders will vote on director elections and auditor ratification, with Daewoong as a key stakeholder.AEON
Proxy filing29 Apr 2026 - Positive biosimilarity results, FDA support, and improved liquidity position ABP-450 for next steps.AEON
Q4 202530 Mar 2026 - ABP-450 targets BOTOX's dominance with a clinically identical, cost-saving biosimilar.AEON
Corporate presentation30 Mar 2026 - Registers 51.3M shares for resale as it seeks U.S. entry for a BOTOX® biosimilar amid going concern risk.AEON
Registration Filing9 Feb 2026 - Shareholders to vote on key financings and equity plan as company seeks biosimilar funding.AEON
Proxy Filing29 Dec 2025
Next AEON Biopharma earnings date
Next AEON Biopharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)